CSIMarket
 
Soleno Therapeutics Inc  (NASDAQ: SLNO)
 

Soleno Therapeutics Inc's Customers Performance

SLNO



 
SLNO's Source of Revenues During the corresponding time, Soleno Therapeutics Inc sequentially revenue grew by 3.13 %. While revenue at the Soleno Therapeutics Inc's corporate clients

List of SLNO Customers




for the same period Soleno Therapeutics Inc sequentially revenue grew by 3.13 %.

List of SLNO Customers

Soleno Therapeutics Inc's Business Units






Soleno Therapeutics Inc's Comment on Sales, Marketing and Customers



The company serves customers under contracts that include variable considerations such as rebates, discounts, returns, and co-pay assistance. Its market segments include U.S. government programs like Medicaid, Medicare, and TRICARE. The company provides trade discounts on VYKAT XR sales for prompt payment and manages distribution services with customers in the distribution channel. Customers have limited rights to return damaged or defective products, with minimal returns historically. Additionally, the company offers co-payment assistance to patients with commercial insurance in states permitting such assistance. Estimates of variable consideration reduce the transaction price and are recorded in the same period as the related product revenue.


  News about Soleno Therapeutics Inc Contracts

Efficacy of DCCR Treatment in Prader-Willi Syndrome: Groundbreaking Results Shed Light on Potential Breakthrough by Soleno Therapeutics

Prader-Willi Syndrome (PWS) is a comple...




Soleno Therapeutics Inc’s Comment on Sales, Marketing and Customers


The company serves customers under contracts that include variable considerations such as rebates, discounts, returns, and co-pay assistance. Its market segments include U.S. government programs like Medicaid, Medicare, and TRICARE. The company provides trade discounts on VYKAT XR sales for prompt payment and manages distribution services with customers in the distribution channel. Customers have limited rights to return damaged or defective products, with minimal returns historically. Additionally, the company offers co-payment assistance to patients with commercial insurance in states permitting such assistance. Estimates of variable consideration reduce the transaction price and are recorded in the same period as the related product revenue.








SLNO's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Soleno Therapeutics Inc 2,813.08 285.01 95.63 182
SUBTOTAL 0.00 0.00 0.00 -

Sources: Soleno Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Soleno Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Soleno Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.